SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter & Gamble Health gains on the BSE

09 Dec 2019 Evaluate

P&G Health is currently trading at Rs. 4262.00, up by 6.00 points or 0.14% from its previous closing of Rs. 4256.00 on the BSE.

The scrip opened at Rs. 4270.35 and has touched a high and low of Rs. 4293.00 and Rs. 4252.45 respectively. So far 219 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 5120.80 on 29-Jul-2019 and a 52 week low of Rs. 2786.50 on 11-Dec-2018.

Last one week high and low of the scrip stood at Rs. 4395.00 and Rs. 4236.35 respectively. The current market cap of the company is Rs. 7058.80 crore.

The promoters holding in the company stood at 51.82%, while Institutions and Non-Institutions held 14.06% and 34.13% respectively.

Procter & Gamble Health (P&G Health) has launched ‘Panache’- a first of its kind platform to support India’s Gen X doctors in their medical education journey. Panache aims to assist students in honing crucial skills for holistic patient care viz. medico-legal aspects, ethics, role of technology, emotional intelligence, decision making, good communication, teamwork, problem solving and leadership among others.

P&G Health (formerly Merck) operates both its pharmaceuticals and chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981.



Procter&Gamble Healt Share Price

5082.10 0.45 (0.01%)
21-Apr-2026 10:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.00
Dr. Reddys Lab 1224.00
Cipla 1231.40
Zydus Lifesciences 931.00
Lupin 2326.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×